Abstract
Purpura is the hallmark of hypergammaglobulinemic purpura (HP). It appears mainly after strenuous activity in the dependent areas of the body. Treatment is mostly symptomatic. Here we report two sisters with Sjogren’s syndrome (SS) and HP who had a remarkable response to colchicine treatment.
Similar content being viewed by others
Abbreviations
- HP:
-
Hypergammaglobulinemic purpura
- RF:
-
Rheumatoid factor
- SS:
-
Sjogren’s syndrome
References
Pines A, Ben-Bassat I (1984) Waldenstrom’s hyperglobulinemic purpura: an unusual immune complex disorder. Clin Rheumatol 3:263–266
Waldenstrom J (1986) Hyperglobulinemic purpura, chronic sialoadenitis and the Sjogren syndrome. Scand J Rheumatol (Suppl) 61:139–141
Katayama I (1995) Clinical analysis of recurrent hypergammaglobulinemic purpura associated with Sjogren syndrome. J Dermatol 22:186–190
Harely JB (1987) Autoantibodies in Sjogren syndrome. In: Talal N, Moutsopoulos HM, Kassan SS, eds. Sjogren syndrome. Clinical and immunological aspects. Springer-Verlag, Berlin, pp 218–234
Pratt PW, Ball GV (1993) Treatment of gout. In: Schumacher ??? , Klippel JH, Koopman WJ, eds. Premier on the rheumatic diseases. The Arthritis Foundation, Atlanta, GA, p 216
Ryne D, Mootoo R, Bhanji A (2001) Colchicine for the treatment of recurrent Henoch-Schonlein purpura in an adult. Rheumatology (Oxford) 40:1430-1431
Marwaha RK, Singh RP, Garewal G, Marwaha N, Prakash D, Sarode R (1990) Colchicine therapy in immune thrombocytopenic purpura. Acta Paediatr Scand 79:1118–1120
Majeed HA, Quabazard Z, Hijazi Z, Farwana S, Harshani F (1990) The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study. QJ Med 75:607–616
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Habib, G.S., Nashashibi, M. Hypergammaglobulinemic purpura in two sisters with Sjogren’s syndrome responding to colchicine treatment. Clin Rheumatol 23, 170–171 (2004). https://doi.org/10.1007/s10067-003-0852-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-003-0852-9